Work

Abstract 6600: Triad-SL: A new synthetic lethality paradigm combining two distinct DNA damage response pathway inhibitors and particle radiotherapy.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-6600

Authors: Neele Haxel, Ivana Dokic, Mahmoud Moustafa, Carmen Klein, Juergen Debus, Amir Abdollahi.

Institutions: German Cancer Research Center, University Hospital Heidelberg, National Center for Tumor Diseases

Language: English

Topic: Radiation Therapy and Dosimetry

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148659766

Cites:

Cited by:

Related to: